Colitis in Medical Technology
Navigation Links
Colitis in Medical Technology
CHICAGO, June 1 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, presented the results of a 5-aminosalicylic acid (5-ASA) persistency analysis entitled, "Twelve-month Persistence with 5-aminosalicylic Acid Therapy: Results from a Lar...
A Separate Retrospective Analysis of US Employer Claims Suggests a Benefit of Anti-Tumor Necrosis Factor Therapies on Absenteeism Among Employees with Inflammatory Bowel Disease SAN DIEGO, May 20 /PRNewswire/ -- Data from a new analysis of the Active Ulcerative Colitis Tri...
SAN DIEGO, May 20 /PRNewswire-FirstCall/ -- A post hoc analysis showing time to symptom resolution data from a study (study 302) of Shire plc's (LSE: SHP, Nasdaq: SHPGY) ulcerative colitis (UC) drug, LIALDA(TM), will be presented today at Digestive Disease Week (DDW). Study 302 (further referr...
Presentation of Phase 1 Clinical Data of MDX-1100 at Digestive Disease Week 2008 PRINCETON, N.J., May 12 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ) announced today that it has initiated the Phase 2 clinical development program of MDX-1100, a fully h...
Findings reinforce the benefits of Asacol for ulcerative colitis patients AVENTURA, Fla., Dec. 5 /PRNewswire/ -- Data from two Phase III clinical trials support that Asacol, an oral, non-steroidal medication that belongs to the class of agents known as 5-aminosalicylic acids (5-ASAs), is an eff...
Symptom resolution results based on stringent endpoint of clinical remission is more clinically relevant, beneficial to patients PHILADELPHIA, Oct. 15 /PRNewswire-FirstCall/ -- An analysis of data to be presented tomorrow at the American College of Gastroenterology (ACG) Annual Scientif...
-- Phase 1 RDEA119 data expected in second half of 2008 -- -- Presentation at the Seventh Annual JMP Securities Research Conference on May 21st canceled; webcast of corporate update scheduled during Ardea's Annual Stockholder Meeting on May 22nd at 9:30 a.m. PT -- SAN DIEGO, May...
4.8 g/day dose using investigational 800 mg tablet demonstrated efficacy and was well tolerated in ASCEND III study SAN DIEGO, May 20 /PRNewswire-FirstCall/ -- In a study presented today at the 39th Annual Digestive Disease Week (DDW) meeting in San Diego, California, 70 percent ...
Post-hoc analysis shows nearly nine out of ten patients taking once-daily Lialda remained relapse free at the end of 12 months WASHINGTON, D.C., May 22, 2007 /PRNewswire-FirstCall/ -- A long-term phase III, open-label 12-14 month extension study (303) presented at the British Society of Gastroente...
Separate Survey Underscores Impact of Disease on Work Status and Productivity WASHINGTON, May 23, 2007 /PRNewswire-FirstCall/ -- Findings presented today at Digestive Disease Week(R) 2007 (DDW), from long-term extensions of the ACT trials (Active Ulcerative Colitis 1 & 2) show that subjects wi...
AM Pharma Continues Its Success with Positive Phase IIa Clinical Trial Results First clinical Results Confirm Potential New Application of Key Product in AM-Pharma's Pipeline BUNNIK, The Netherlands, July 9, 2007-AM-Pharma B.V., the biopharmaceutical company developing novel therapeutics to trea...
...is (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), ulcerative colitis (UC), pediatric Crohn's disease (PCD) and psoriasis (PsO). The safety and ...d mostly in teenage or young adult males with Crohn's disease or ulcerative colitis who were taking REMICADE and azathioprine or 6-mercaptopurine. Hear...
...ve tract. The trafficking of T cells to the small and large intestine causes persistent inflammation that may result in Crohn's disease or ulcerative colitis - the two principal forms of IBD. In preclinical studies, the compound worked both therapeutically and prophylactically in models of Crohn's disease ...
...nge of inflammatory diseases, including ulcerative colitis in an ongoing companion Phase 2 study." Abou... also being explored as a treatment for ulcerative colitis (UC). A Phase 2 randomized, double-blind, placebo-...ammation ascertained by endoscopy. Ulcerative colitis is a chronic inflammatory bowel disease characteri...
...d arthritis and interstitial nephritis), pulmonary disorders (dyspnea, pneumonia, bronchiolitis obliterans, interstitial pneumonitis and sarcoidosis), colitis (ulcerative and hemorrhagic/ischemic colitis), pancreatitis, and ophthalmologic disorders (decrease or loss of vision, retinopathy including macular e...
...d arthritis and interstitial nephritis), pulmonary disorders (dyspnea, pneumonia, bronchiolitis obliterans, interstitial pneumonitis and sarcoidosis), colitis (ulcerative and hemorrhagic/ischemic colitis), pancreatitis, and ophthalmologic disorders (decrease or loss of vision, retinopathy including macular e...
...ializes Vancocin(R) (vancomycin hydrochloride capsules, USP), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains, and Cinryze(TM) (C1 in...
...tudies to Investigate Novel Therapy for Ulcerative colitis and Crohn's Disease OSAKA, Japan, Jan. 22 /PR... study vedolizumab for the treatment of ulcerative colitis and Crohn's disease, the two main types of IBD. De... Failure of current medical therapy for ulcerative colitis and Crohn's disease frequently leads to surgical r...
...d arthritis and interstitial nephritis), pulmonary disorders (dyspnea, pneumonia, bronchiolitis obliterans, interstitial pneumonitis and sarcoidosis), colitis (ulcerative and hemorrhagic/ischemic colitis), pancreatitis, and ophthalmologic disorders (decrease or loss of vision, retinopathy including macular e...
...today that a poster entitled "RDEA119, a Potent and Highly Selective MEK1/2 Inhibitor is Beneficial in Dextran Sulfate Sodium (DSS) -- induced Chronic colitis in Mice," was presented at the American College of Gastroenterology (ACG) 2008 Annual Meeting in Orlando, Florida. The poster, which provided data fro...
...nstrated broad clinical utility in Crohn's disease (CD), rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), ulcerative colitis (UC), pediatric Crohn's disease (PCD) and psoriasis (PsO). The safety and efficacy of REMICADE have been well established in clinical trials over the ...
...he Company has completed a Phase IIb study evaluating Simulect(R) (basiliximab) for the treatment of moderate-to-severe, steroid-refractory ulcerative colitis (UC) and expects data shortly. Cerimon is also evaluating Simulect in a Phase II study in individuals with noninfectious uveitis. Furthermore, based u...
...A119, a Potent and Highly Selective MEK1 / 2 Inhibitor is Beneficial in Dextran Sulfate Sodium (DSS)-Induced Chronic colitis in Mice" Poster Number: P1050 Session Title: Inflammatory Bowel Disease Location: Florida Exhibit Halls About Ardea Biosciences, Inc. Ardea Bi...
...sents a breakthrough mechanism of action for inflammatory disease and is being investigated in separate Phase 2 proof-of-concept trials for ulcerative colitis and rheumatoid arthritis. Interim data from these trials are expected in 2009. -- MDX-1401 is a fully human antibody that targets CD30, a member of ...
...b study for patients with moderate-to-severe, steroid-refractory ulcerative colitis (UC) in April 2007. "The initiation of this proof-of-concept study is par...tudy for the treatment of moderate-to-severe, steroid-refractory ulcerative colitis the following year. In December 2007, Cerimon entered into an agreement wit...
...ive tract. The trafficking of T cells to the small and large intestine causes persistent inflammation that may result in Crohn's disease or ulcerative colitis - the two principal forms of IBD. In preclinical studies, the compound worked both therapeutically and prophylactically in models of Crohn's disease a...
...ms that responded to oral corticosteroid treatment. Of the 11 patients that were eligible for re-treatment, one patient with ocular melanoma developed colitis 3 weeks after receiving a fifth dose of 1 mg/kg (over 9 months), and is improving with medical treatment of this immune- related adverse event after d...
...(CDAD) has been reported with use of nearly all antibacterial agents, including TYGACIL, and may range in severity from mild diarrhea to fatal colitis -- Concurrent use of antibacterial drugs with oral contraceptives may render oral contraceptives less effective -- The use of TYGACIL during too...
A Separate Retrospective Analysis of US Employer Claims Suggests a Benefit of Anti-Tumor Necrosis Factor Therapies on Absenteeism Among Employees with Inflammatory Bowel Disease SAN DIEGO, May 20 /PRNewswire/ -- Data from a new analysis of the Active Ulcerative Colitis Tri...
SAN DIEGO, May 20 /PRNewswire-FirstCall/ -- A post hoc analysis showing time to symptom resolution data from a study (study 302) of Shire plc's (LSE: SHP, Nasdaq: SHPGY) ulcerative colitis (UC) drug, LIALDA(TM), will be presented today at Digestive Disease Week (DDW). Study 302 (further referr...
Presentation of Phase 1 Clinical Data of MDX-1100 at Digestive Disease Week 2008 PRINCETON, N.J., May 12 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ) announced today that it has initiated the Phase 2 clinical development program of MDX-1100, a fully h...
Findings reinforce the benefits of Asacol for ulcerative colitis patients AVENTURA, Fla., Dec. 5 /PRNewswire/ -- Data from two Phase III clinical trials support that Asacol, an oral, non-steroidal medication that belongs to the class of agents known as 5-aminosalicylic acids (5-ASAs), is an eff...
Symptom resolution results based on stringent endpoint of clinical remission is more clinically relevant, beneficial to patients PHILADELPHIA, Oct. 15 /PRNewswire-FirstCall/ -- An analysis of data to be presented tomorrow at the American College of Gastroenterology (ACG) Annual Scientif...
-- Phase 1 RDEA119 data expected in second half of 2008 -- -- Presentation at the Seventh Annual JMP Securities Research Conference on May 21st canceled; webcast of corporate update scheduled during Ardea's Annual Stockholder Meeting on May 22nd at 9:30 a.m. PT -- SAN DIEGO, May...
4.8 g/day dose using investigational 800 mg tablet demonstrated efficacy and was well tolerated in ASCEND III study SAN DIEGO, May 20 /PRNewswire-FirstCall/ -- In a study presented today at the 39th Annual Digestive Disease Week (DDW) meeting in San Diego, California, 70 percent ...
Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many Aspects of Daily Life
UC's Overall Psychological Toll Is Greater Than for Asthma, Rheumatoid Arthritis and Migraines WAYNE, Pa., May 17, 2007 /PRNewswire/ -- Nearly three out of four ulcerative colitis (UC) sufferers (73 percent) responding to a new nationwide survey say not feeling well has become a normal part of lif...Post-hoc analysis shows nearly nine out of ten patients taking once-daily Lialda remained relapse free at the end of 12 months WASHINGTON, D.C., May 22, 2007 /PRNewswire-FirstCall/ -- A long-term phase III, open-label 12-14 month extension study (303) presented at the British Society of Gastroente...
Separate Survey Underscores Impact of Disease on Work Status and Productivity WASHINGTON, May 23, 2007 /PRNewswire-FirstCall/ -- Findings presented today at Digestive Disease Week(R) 2007 (DDW), from long-term extensions of the ACT trials (Active Ulcerative Colitis 1 & 2) show that subjects wi...
Callisto Intends to Move Guanilib into Clinical Trials in Ulcerative Colitis
Announces Positive Data in Animal Models of Ulcerative Colitis NEW YORK, April 05, 2007 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. , a developer of new drug treatments in the fight against cancer and other major health threats, announced today additional data confirming efficacy of G...Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
LONDON, 2 July 2007: Chi-Med, the Hutchison Whampoa backed pharmaceutical and healthcare Group, today announces positive results for its Phase II proof-of-concept study for HMPL-004 in mild-to-moderate Ulcerative Colitis, a form of inflammatory bowel disease. The trial met its objectiv...AM Pharma Continues Its Success with Positive Phase IIa Clinical Trial Results First clinical Results Confirm Potential New Application of Key Product in AM-Pharma's Pipeline BUNNIK, The Netherlands, July 9, 2007-AM-Pharma B.V., the biopharmaceutical company developing novel therapeutics to trea...
Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets
... for the treatment of moderately active ulcerative colitis (UC), a form of inflammatory bowel disease. UC inv...ercent in ASCEND II. (1,2) About Ulcerative colitis (UC) UC involves inflammation of the lining of...Asacol or Asacol HD therapy. Acute exacerbation of colitis symptoms can also occur. Caution should be exercis......is (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), ulcerative colitis (UC), pediatric Crohn's disease (PCD) and psoriasis (PsO). The safety and ...d mostly in teenage or young adult males with Crohn's disease or ulcerative colitis who were taking REMICADE and azathioprine or 6-mercaptopurine. Hear...
Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW
...IBD vs. non-IBD and Crohn's disease vs. ulcerative colitis than using traditional cutoff value analysis of th... difference between Crohn's disease and ulcerative colitis is the location and nature of the inflammation. Be...use the symptoms of Crohn's disease and ulcerative colitis are so similar, it is sometimes difficult to estab......ve tract. The trafficking of T cells to the small and large intestine causes persistent inflammation that may result in Crohn's disease or ulcerative colitis - the two principal forms of IBD. In preclinical studies, the compound worked both therapeutically and prophylactically in models of Crohn's disease ...
Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop
...ializes Vancocin(R) (vancomycin hydrochloride capsules, USP), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains, and Cinryze(TM) (C1 es......nge of inflammatory diseases, including ulcerative colitis in an ongoing companion Phase 2 study." Abou... also being explored as a treatment for ulcerative colitis (UC). A Phase 2 randomized, double-blind, placebo-...ammation ascertained by endoscopy. Ulcerative colitis is a chronic inflammatory bowel disease characteri...
...d arthritis and interstitial nephritis), pulmonary disorders (dyspnea, pneumonia, bronchiolitis obliterans, interstitial pneumonitis and sarcoidosis), colitis (ulcerative and hemorrhagic/ischemic colitis), pancreatitis, and ophthalmologic disorders (decrease or loss of vision, retinopathy including macular e...
...d arthritis and interstitial nephritis), pulmonary disorders (dyspnea, pneumonia, bronchiolitis obliterans, interstitial pneumonitis and sarcoidosis), colitis (ulcerative and hemorrhagic/ischemic colitis), pancreatitis, and ophthalmologic disorders (decrease or loss of vision, retinopathy including macular e...
ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
...reatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocoliti...reated with Vancocin Capsules for pseudomembranous colitis caused by C. difficile. It is noteworthy that t...reatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocoliti...ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
...ializes Vancocin(R) (vancomycin hydrochloride capsules, USP), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains, and Cinryze(TM) (C1 in......ializes Vancocin(R) (vancomycin hydrochloride capsules, USP), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains, and Cinryze(TM) (C1 in...
...tudies to Investigate Novel Therapy for Ulcerative colitis and Crohn's Disease OSAKA, Japan, Jan. 22 /PR... study vedolizumab for the treatment of ulcerative colitis and Crohn's disease, the two main types of IBD. De... Failure of current medical therapy for ulcerative colitis and Crohn's disease frequently leads to surgical r...
ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
...ializes Vancocin(R) (vancomycin hydrochloride capsules, USP), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains, and Cinryze(TM) (C1 inhibi......d arthritis and interstitial nephritis), pulmonary disorders (dyspnea, pneumonia, bronchiolitis obliterans, interstitial pneumonitis and sarcoidosis), colitis (ulcerative and hemorrhagic/ischemic colitis), pancreatitis, and ophthalmologic disorders (decrease or loss of vision, retinopathy including macular e...
ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
...ializes Vancocin(R) (vancomycin hydrochloride capsules, USP), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains, and Cinryze (C1 inhibitor ......today that a poster entitled "RDEA119, a Potent and Highly Selective MEK1/2 Inhibitor is Beneficial in Dextran Sulfate Sodium (DSS) -- induced Chronic colitis in Mice," was presented at the American College of Gastroenterology (ACG) 2008 Annual Meeting in Orlando, Florida. The poster, which provided data fro...
...nstrated broad clinical utility in Crohn's disease (CD), rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), ulcerative colitis (UC), pediatric Crohn's disease (PCD) and psoriasis (PsO). The safety and efficacy of REMICADE have been well established in clinical trials over the ...
...he Company has completed a Phase IIb study evaluating Simulect(R) (basiliximab) for the treatment of moderate-to-severe, steroid-refractory ulcerative colitis (UC) and expects data shortly. Cerimon is also evaluating Simulect in a Phase II study in individuals with noninfectious uveitis. Furthermore, based u...
...A119, a Potent and Highly Selective MEK1 / 2 Inhibitor is Beneficial in Dextran Sulfate Sodium (DSS)-Induced Chronic colitis in Mice" Poster Number: P1050 Session Title: Inflammatory Bowel Disease Location: Florida Exhibit Halls About Ardea Biosciences, Inc. Ardea Bi...
New Genes Found for Inflammatory Bowel Disease in Children
...ach patient." The study team also found an association between ulcerative colitis and genes on the major histocompatiblity complex (MHC) on chromosome 6. The...onal Institutes of Health, the IBD Family Research Council, the Crohn's and colitis Foundation of America, the Koss Foundation, the NIH General Clinical Resear......sents a breakthrough mechanism of action for inflammatory disease and is being investigated in separate Phase 2 proof-of-concept trials for ulcerative colitis and rheumatoid arthritis. Interim data from these trials are expected in 2009. -- MDX-1401 is a fully human antibody that targets CD30, a member of ...
...b study for patients with moderate-to-severe, steroid-refractory ulcerative colitis (UC) in April 2007. "The initiation of this proof-of-concept study is par...tudy for the treatment of moderate-to-severe, steroid-refractory ulcerative colitis the following year. In December 2007, Cerimon entered into an agreement wit...
Current Concepts in Clostridium difficile Infection: A Focus on Recurrent Disease
... difficile infection (CDI) is a serious condition that causes disease with a wide spectrum of severity, ranging from mild diarrhea to pseudomembranous colitis and death. Recurrent CDI can occur in up to 20% of patients who develop an initial case of CDI.(1) These patients are at increased risk of additional ......ive tract. The trafficking of T cells to the small and large intestine causes persistent inflammation that may result in Crohn's disease or ulcerative colitis - the two principal forms of IBD. In preclinical studies, the compound worked both therapeutically and prophylactically in models of Crohn's disease a...
...ms that responded to oral corticosteroid treatment. Of the 11 patients that were eligible for re-treatment, one patient with ocular melanoma developed colitis 3 weeks after receiving a fifth dose of 1 mg/kg (over 9 months), and is improving with medical treatment of this immune- related adverse event after d...
...(CDAD) has been reported with use of nearly all antibacterial agents, including TYGACIL, and may range in severity from mild diarrhea to fatal colitis -- Concurrent use of antibacterial drugs with oral contraceptives may render oral contraceptives less effective -- The use of TYGACIL during too...
Other TagsKatrinaKatrinaCattleBiggerBiggerPolymerPolymerPolymerPolymerMagneticMagneticMagneticDangerousDangerousEarliestRussianCenterCenterCenterCenterOther Contentsinnerinnerinnerinnerinnerinnerinnerinnerinnermutationsmutationsmutationsmutationsmutationsmutationsmutationsmutationsinsertioninsertioninsertioninsertioninsertioninsertioninsertionintegrationintegrationintegrationintegrationintegrationintegrationintegrationintegrationintegumentintein
UnderlyingKatrinaCattleBiggerStoringPolymerMagneticDangerousGeoscientistsEarliestRussianRemovingCenterToasty
(Date:12/1/2009)...disease, nerve cell degeneration plays a crucial r...ssibly be derived from steering the generation and...published in the current issue of the renowned jou... ago, neurogenesis the process of nerve cell deve...ult brain. The textbooks asserted that dead nerve ...
(Date:12/1/2009)...from the United States, the other from Canada, put... wolf pack, on remote Ellesmere Island, only 600 m...ind out what these "North Pole wolves" do in the l...eas of the world., "We first encountered 9-year-...ned U.S. Geological Survey (USGS) wolf researcher ...
(Date:12/1/2009)...,abominable mystery, and it is a question which ha... did flowering plants evolve and how did they come... Ecology Letters reveals the evolutionary trigge...jor competitive advantage over rival species, lead...e study, by Dr Tim Brodribb and Dr Taylor Field o...
Breaking Biology News(10 mins):New source discovered for the generation of nerve cells in the brain 2North Pole wolf emails locations to researchers 2North Pole wolf emails locations to researchers 3How did flowering plants evolve to dominate Earth? 2Catholics for Choice Statement on Antiabortion Amendment to Healthcare Reform Bill 60898 1Bishops Urge Passage of Stupak Ellsworth Anti Abortion Amendment for Health Reform Bill 60896 1Bishops Urge Passage of Stupak Ellsworth Anti Abortion Amendment for Health Reform Bill 60896 2Americans United for Life Action Endorses a Vote for the Stupak Ellsworth Pitts Kaptur Dahlkemper Lipinski Smith Amendment and Sends Score Letter to H 60894 1Americans United for Life Action Endorses a Vote for the Stupak Ellsworth Pitts Kaptur Dahlkemper Lipinski Smith Amendment and Sends Score Letter to H 60894 2(Date:12/1/2009)...ON, Dec. 1 With employee...number of employers are providing self-service dec...nt season, according to a new survey by Watson Wya...f employers who offer these tools believe they lea...s. ,, According to the survey, 45 percent of co...
(Date:12/1/2009)...ITY, Dec. 1 The government of Mexi...s center for biomedical and nanomedical research, ...al research and development will be integrated wit...e top Spanish speaking university in the world. T...on in 2010, has been designed by the international...
(Date:12/1/2009)...INGTON, Dec. 1 On Decem...d 1,538 federal prisoners were HIV positive or had...(BJS) in the Office of Justice Programs, U.S. Depa...8, an estimated 5,672 inmates in state and federal...07. In 2007, about 43 per 10,000 prison inmates we...
(Date:12/1/2009)...D, Mich., Dec. 1 First ...rst Mercury" or the "Company") announced today tha...ared a quarterly cash dividend of $0.025 per share...record at the close of business on December 15, 20...tion ,, First Mercury Financial Corporation pr...
(Date:12/1/2009)... Central and South America, study finds , ...ercent of intensive care unit patients worldwide s...ng in the hospital, a new study finds. , Resear... 8, 2007) on 13,796 patients, aged 18 and older, i...ercent of patients were classified as infected and...
Breaking Medicine News(10 mins):Health News:Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds 2Health News:Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds 3Health News:Mexico City to Build World-Class Hub for Medical Research 2Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 2Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 3Health News:Half of ICU Patients Suffer From Infections 2[0] Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds[1] Mexico City to Build World-Class Hub for Medical Research[0] Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population[0] First Mercury Financial Corporation Declares Dividend[0] Half of ICU Patients Suffer From Infections
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |